Article Text

other Versions

PDF
Change in viral bronchiolitis management in primary care in the UK after the publication of NICE guideline
  1. Elliott J Carande1,
  2. C Ronny Cheung2,
  3. Andrew J Pollard3,
  4. Simon B Drysdale3
  1. 1Royal Gwent Hospital, Aneurin Bevan Health Board, Newport, UK
  2. 2Department of General Paediatrics, Evelina London Children’s Hospital, London, UK
  3. 3Department of Paediatrics, Oxford Vaccine Group, University of Oxford, The NIHR Oxford Biomedical Research Centre, Children’s Hospital, Oxford, UK
  1. Correspondence to Dr Simon B Drysdale, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, The NIHR Oxford Biomedical Research Centre, Children’s Hospital, Oxford OX3 9DU, UK; simon.drysdale{at}paediatrics.ox.ac.uk

Abstract

The aim of this study was to investigate changes in general practitioner (GP) management before and after the publication of the National Institute for Health and Care Excellence bronchiolitis guideline. In March 2015 and May 2016, an electronic questionnaire was sent to GPs. It was completed by 1001 GPs in 2015 and 1009 in 2016. There were small but significant improvements in proportions of GPs using a guideline, measuring oxygen saturations and providing written guidance, and appropriate reductions in those prescribing medications. Thirty-five per cent had read the guideline and 25% changed their practice since guideline publication. There were modest but significant improvements in reported management by GPs after guideline publication.

  • paediatric lung disease
  • respiratory infection
  • viral infection

Statistics from Altmetric.com

Footnotes

  • Contributors SBD, CRC and AJP designed the study. EJC and SBD collected and analysed the data. EJC wrote the initial draft. All authors reviewed the article and agreed on the final manuscript.

  • Funding The study was funded by the Medical Sciences Division Medical Research Fund, University of Oxford and the Oxfordshire Health Services Research Committee (OHSRC). The funders had no role in the design, data collection or analysis, interpretation, write-up or decision for article submission of the project.

  • Competing interests AJP has previously conducted vaccine clinical trials on behalf of Oxford University funded by vaccine manufacturers but he no longer does so and did not receive any personal reimbursement from them. AJP is chair of the Department of Health’s (DH) Joint Committee on Vaccination and Immunisation (JCVI) but the reviews expressed herein do not necessarily represent those of DH or JCVI. Other authors have no competing interest to declare.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles